https://gizmodo.com/lung-cancer-pill-cuts-risk-of-dying-by-half-in-major-tr-1850507356
0
0
6/5/23 at 7:50pm
Organization
Gizmodo.com
Author
Ed Cara
AstraZeneca's osimertinib, in combination with surgery, substantially improved the long-term survival of patients with a common form of lung cancer.
Create an account
or login to join the discussion